Back
Atara Biotherapeutics Vs. UniFirst Industry Stock Comparison
Buy
60
ATRA
Atara Biotherapeutics
Last Price:
$16.39
Seasonality Move:
5.9%
Buy
73
UNF
UniFirst
Last Price:
$214.87
Seasonality Move:
1.02%
Buy
60
Atara Biotherapeutics (ATRA)
is a Buy
Is Atara Biotherapeutics a Buy, Sell or Hold?
-
The current Atara Biotherapeutics [ATRA] share price is $16.53. The Score for ATRA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ATRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATRA Stock Price Chart
What is Atara Biotherapeutics's stock price today?
-
The Atara Biotherapeutics share price today is $16.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRA is experiencing slight buying pressure.
ATRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.37 | Buy |
Relative Strength Index (14 RSI): | 66.4 | Buy |
Chaikin Money Flow: | 26265 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.66 - 14.94) | Buy |
Bollinger Bands (100): | (7.52 - 12.48) | Buy |
UNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 72.95 | Buy |
Chaikin Money Flow: | 380542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (173.47 - 198.41) | Buy |
Bollinger Bands (100): | (180.75 - 197.95) | Buy |
ATRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.08 | Buy |
20-day SMA: | 12.82 | Buy |
50-day SMA: | 11.97 | Buy |
200-day SMA: | 11.6 | Buy |
8-day EMA: | 15.42 | Buy |
20-day EMA: | 13.75 | Buy |
50-day EMA: | 12.16 | Buy |
200-day EMA: | 14.22 | Buy |
UNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 180.62 | Buy |
20-day SMA: | 183.05 | Buy |
50-day SMA: | 190.15 | Buy |
200-day SMA: | 178.74 | Buy |
8-day EMA: | 187.59 | Buy |
20-day EMA: | 185.11 | Buy |
50-day EMA: | 187.72 | Buy |
200-day EMA: | 182.46 | Buy |
Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $11.80 per share, a decrease next quarter of $0.00 per share, a decrease this year of $10.45 per share, and an increase next year of $5.50 per share.
UniFirst Earnings Growth & UNF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.98 per share, a decrease this year of $0.14 per share, and an increase next year of $0.92 per share.
Atara Biotherapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
UniFirst Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |